CME Group Inc. (NASDAQ:CME) COO Julie Holzrichter sold 11,915 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $125.67, for a total value of $1,497,358.05. Following the sale, the chief operating officer now owns 43,657 shares of the company’s stock, valued at approximately $5,486,375.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Julie Holzrichter also recently made the following trade(s):

  • On Wednesday, June 7th, Julie Holzrichter sold 5,925 shares of CME Group stock. The shares were sold at an average price of $118.23, for a total value of $700,512.75.

Shares of CME Group Inc. (CME) traded down 0.17% during midday trading on Tuesday, reaching $124.76. The company had a trading volume of 774,995 shares. The company has a market capitalization of $42.24 billion, a P/E ratio of 25.47 and a beta of 0.73. The company has a 50-day moving average price of $123.71 and a 200 day moving average price of $120.57. CME Group Inc. has a one year low of $98.95 and a one year high of $127.96.

CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping the Zacks’ consensus estimate of $1.20 by $0.03. The business had revenue of $925 million during the quarter, compared to analyst estimates of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.14 EPS. Equities analysts anticipate that CME Group Inc. will post $4.81 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s payout ratio is 53.99%.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: CME Group Inc. (CME) COO Sells 11,915 Shares of Stock” was reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/08/08/insider-selling-cme-group-inc-cme-coo-sells-11915-shares-of-stock.html.

Several equities research analysts have recently commented on CME shares. Royal Bank Of Canada decreased their price objective on CME Group from $134.00 to $133.00 and set an “outperform” rating for the company in a report on Wednesday, April 19th. Deutsche Bank AG reiterated a “buy” rating and set a $133.00 price target (down previously from $134.00) on shares of CME Group in a report on Monday, May 15th. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. BidaskClub upgraded CME Group from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $134.00 price target (up previously from $128.00) on shares of CME Group in a report on Monday, July 17th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $131.63.

Several hedge funds have recently bought and sold shares of the company. Girard Partners LTD. raised its stake in CME Group by 27.4% in the second quarter. Girard Partners LTD. now owns 2,847 shares of the financial services provider’s stock worth $357,000 after buying an additional 613 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in CME Group by 10.1% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 7,466 shares of the financial services provider’s stock worth $935,000 after buying an additional 682 shares during the last quarter. Hudock Capital Group LLC raised its stake in CME Group by 0.5% in the second quarter. Hudock Capital Group LLC now owns 3,890 shares of the financial services provider’s stock worth $487,000 after buying an additional 20 shares during the last quarter. Buckingham Asset Management LLC raised its stake in CME Group by 10.4% in the second quarter. Buckingham Asset Management LLC now owns 2,949 shares of the financial services provider’s stock worth $369,000 after buying an additional 278 shares during the last quarter. Finally, Neuberger Berman Group LLC raised its stake in CME Group by 0.5% in the second quarter. Neuberger Berman Group LLC now owns 2,838,544 shares of the financial services provider’s stock worth $355,500,000 after buying an additional 14,605 shares during the last quarter. 83.29% of the stock is owned by institutional investors and hedge funds.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.